Advertisement

Topics

Seattle Genetics Announces Data Presentations at 2018 ASCO Annual Meeting

08:00 EDT 17 May 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that multiple abstracts from its robust clinical development portfolio will be presented at the upcoming 2018 American Society of Clinical Oncology (ASCO) Annual Meetin...

Other Sources for this Article

Seattle Genetics, Inc.
Media:
Monique Greer, 425-527-4641
mgreer@seagen.com
or
Investors:
Peggy Pinkston, 425-527-4160
ppinkston@seagen.com

NEXT ARTICLE

More From BioPortfolio on "Seattle Genetics Announces Data Presentations at 2018 ASCO Annual Meeting"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...